Ticker Scorecard - CRNX Basics Company: Crinetics Pharmaceuticals, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $3.47B Activated in VL: True Average Daily Range Avg Daily Range: $0.66 | 2.72% Avg Daily Range (30 D): $1.00 | 2.50% Avg Daily Range (90 D): $1.09 | 2.18% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .86M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 51 Institutional Trades Total Inst.Trades: 2,042 Avg Inst. Trade: $2.34M Avg Inst. Trade (30 D): $1.87M Avg Inst. Trade (90 D): $3.12M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.54M Avg Closing Trade (30 D): $4.22M Avg Closing Trade (90 D): $7.28M Avg Closing Volume: 103.41K     News Feb 6, 2025 @ 9:35 PM Crinetics Pharmaceuticals to Report Fourth Quarter... Source: N/A Jan 10, 2025 @ 12:00 PM Crinetics Announces Positive Topline Results From ... Source: N/A Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Dec 16, 2024 @ 2:10 PM Neurocrine's Drug Gains FDA Nod As First Targeted ... Source: Vandana Singh Dec 11, 2024 @ 1:44 AM Crinetics Pharmaceuticals Announces December 2024 ... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.96 $-.94 $-.93 Diluted EPS $-.96 $-.94 $-.93 Revenue $ M $ .4M $ .64M Gross Profit $ $ $ Net Income / Loss $ -76.83M $ -74.06M $ -66.93M Operating Income / Loss $ -87.8M $ -82.78M $ -73.53M Cost of Revenue $ $ $ Net Cash Flow $ 15.11M $ -93.76M $ 341.03M PE Ratio